Category

Investing

Category

Westport Fuel Systems Inc. (‘Westport’) (TSX:WPRT Nasdaq: WPRT), a supplier of alternative fuel systems and components for the global transportation industry, today announces changes to its Board of Directors. Chair Dan Hancock, appointed to the Board in July 2017, retired from the Board, effective December 31, 2025, with current director Tony Guglielmin assuming the role of Chair. Joining Westport’s Board of Directors, effective January 1, 2026, is Brad Kotush, who brings over 20 years of experience in early-stage transformation, investment banking, and capital markets, both in Canada and globally. This addition further enhances the Board’s expertise and supports the Company’s long-term strategic objectives.

Mr. Hancock’s extensive automotive experience, particularly in technology commercialization and European manufacturing leadership, proved essential as Westport navigated the rapidly shifting dynamics of today’s automotive industry,’ said Tony Guglielmin, appointed Chair of Westport’s Board of Directors. ‘During the integration process following the 2016 merger and the commercialization of the HPDI fuel system, Mr. Hancock provided the stability and insight necessary for success. We are grateful for his dedication and the legacy he leaves with the Board.’

‘Brad Kotush’s appointment adds exceptional strength to our Board,’ added Guglielmin. ‘Mr. Kotush’s background in executive-level finance, risk management, and strategy spanning clean technology, investment banking, and global capital markets aligns directly with Westport’s strategic direction. His experience overseeing regulated entities, major financing programs, and cross-border transactions will bring meaningful insight and discipline to our governance and decision-making processes.’

Mr. Kotush is currently the CFO of a clean tech company listed on the TSXV and previously held the positions of Executive Vice President and Chief Financial Officer at Home Capital Group Inc. and Executive Vice President, Chief Financial and Risk Officer at Canaccord Genuity Group Inc.

About Westport Fuel Systems

Westport is a technology and innovation company connecting synergistic technologies to power a cleaner tomorrow. As a leading supplier of affordable, alternative fuel, low-emissions transportation technologies, we design, manufacture, and supply advanced components and systems that enable the transition from traditional fuels to cleaner energy solutions.

Our proven technologies support a wide range of clean fuels – including natural gas, renewable natural gas, and hydrogen – empowering OEMs and commercial transportation industries to meet performance demands, regulatory requirements, and climate targets in a cost-effective way. With decades of expertise and a commitment to engineering excellence, Westport is helping our partners achieve sustainability goals—without compromising performance or cost-efficiency – making clean, scalable transport solutions a reality.

Westport is headquartered in Vancouver, Canada. For more information, visit Westport.com.

Contact Information

Investor Relations
Westport Fuel Systems
T: +1 604-718-2046     

News Provided by GlobeNewswire via QuoteMedia

This post appeared first on investingnews.com

Josef Schachter, president and author at the Schachter Energy Report, shares his thoughts on oil and natural gas prices, supply and demand in 2026.

‘I think before the cycle is over, the 2007 high of US$147 (per barrel) will be breached, because the industry cannot respond quickly by bringing on new oil,’ he said.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

A securities lawsuit involving DeFi Technologies (NASDAQ:DEFT) highlights growing regulatory scrutiny on corporate crypto treasury strategies, signaling risks for investors eyeing similar plays.

While many crypto firms have faced class actions, the difference with the DeFi Technologies case is apparent: it targets operational delays and disclosure risks within a corporate treasury.

Most previous crypto lawsuits have concentrated on more common issues, such as promoter liability, token sales or exchange collapses, which primarily hit platforms and promoters.

Specifically, the DeFi Technologies lawsuit alleges that the company hid delays in its core DeFi arbitrage trading, its main revenue driver, while downplaying competition from rival digital asset treasury firms (DATs).

The class action, which seeks to represent those who purchased or acquired DeFi Technologies shares between May 12 and November 14 of this year, comes after two recent share price drops for the company.

Amid emerging risks in the DeFi space, the governance expert emphasized the need for clear business strategies and disclosures to shareholders, and highlighted the role of independent third-party advisors to protect boards.

DeFi Technologies lawsuit breakdown

Plaintiffs claim that DeFi Technologies misled investors from May to November 2025 by issuing revenue guidance of US$218.6 million, despite arbitrage execution snags and rivals eroding its edge.

The company’s share price fell more than 7 percent on November 6 after it issued an update, then crashed over 27 percent between November 14 and 17. The second decline was triggered by the release of its Q3 results — the firm reported a 20 percent revenue miss, cut its 2025 guidance to US$116.6 million and shifted its CEO to an advisory role.

Unlike typical crypto suits over token sales or exchange collapses, this one targets a corporate treasury’s operational delays in DeFi yield strategies, exposing how arbitrage hiccups and DAT rivals demand precise disclosures.

“I think it’s an indicator that we’re going to see more questions and concerns surrounding the regulatory environment and disclosures, because we kind of hit into uncharted … territory very rapidly,” said Bishara.

The lawsuit arrives amid new fair-value accounting rules, testing board liability for strategy risks before 2026 filings.

Operational value vs. crypto laundering

An emerging concern for regulators and investors is the distinction between companies with genuine transactional components and those using public markets to create artificial liquidity.

Bishara noted that smaller companies divesting from core businesses to pivot toward crypto could become targets for regulatory scrutiny due to a perceived change in control.

From his perspective, firms primarily pursuing a treasury strategy could come under fire for potentially prioritizing short-term stock value and liquidation over the best interests of shareholders.

In these smaller transactions, Bishara suggested that the shift can be viewed as a way to convert illiquid digital assets into US dollars by selling stock in the open market.

“You’re converting something that I can’t really sell, and I can’t really buy a piece of pizza with … and turning it into something that I can buy a piece of pizza with,” the expert explained. “It’s almost like laundering crypto into currency,” he added, clarifying that this is not a one-size-fits-all accusation.

Consequently, he believes investors should look for companies whose underlying business models have operational potential, rather than those focused purely on digital asset transactions.

Board oversight and fiduciary duty

The rapid evolution of DeFi has fundamentally outpaced the regulatory frameworks designed to govern it.

For investors, the DeFi Technologies case underscores the danger of imprecise disclosures around crypto assets, particularly when firms pivot their strategies without clear communication to shareholders.

Bishara observed that as stock volatility triggers these types of lawsuits, corporate boards are being forced to rethink the practical applications of their fiduciary responsibility.

To fulfill their duty to shareholders, the expert argued that boards must engage in active, expert-led evaluation. Engaging independent third-party advisors, such as attorneys or investment bankers, to evaluate crypto treasury deals will insulate and help companies protect themselves in this uncharted territory.

From his perspective, this process effectively transfers some of the risk from board members to advisors.

Bishara further emphasized the importance of documenting the specific evaluation of a transaction in board minutes, noting that if a director disagrees with a crypto strategy, they should “disagree with it in the minutes” in order to ensure that their individual interests are protected.

The need for rigorous board oversight is being driven home by the insurance market. Bishara observed that even if a company’s actual risk profile has not changed, the cost of mitigating risk through Directors and Officers (D&O) insurance is skyrocketing as the number of carriers willing to underwrite these risks has shrunk significantly.

“I am quite certain that we are going to see policy language that specifically discusses or removes some of these potential pieces of liability, specifically in companies that are not insuring for these types of transactions,” Bishara predicted, adding that standard insurance companies will likely add no-crypto clauses to their policies.

“I would definitely expect that more, not from the crypto underwriters, but more from the non-crypto underwriters, to really make sure that they’re not winding up on a risk accidentally,’ he also noted.

For investors, Bishara suggested that a company’s inability to secure affordable D&O insurance should be viewed as a significant red flag regarding the health of its balance sheet.

Investor takeaway

Bishara’s front-row seat to operational crypto-utility and high-frequency transactional modeling has helped shape his view of where the market is headed in 2026 and beyond. While the DAT model dominated the 2024/2025 cycle, he believes the space is rapidly evolving into a new phase of business.

“I think it’s a great space for really exploring how the world is going to evolve and change,” he said.

For investors, the key to long-term value may lie in distinguishing between a company that is simply HODLing, and a firm that is building a transactional component.

Bishara pointed to emerging business models where firms are moving beyond treasury strategies to become operational, transactional companies that use crypto to power everyday transactions.

As the 2026 regulatory and insurance landscape tightens, focus will likely shift away from those chasing short-term stock premiums and toward those using DeFi to build sustainable, potentially undervalued business models.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

VANCOUVER, BC / ACCESS Newswire / December 31, 2025 / Goldgroup Mining Inc. (‘Goldgroup‘ or the ‘Company‘) (TSXV:GGA,OTC:GGAZF)(OTCQX:GGAZF).

Goldgroup announces that, subject to the final approval of the TSX Venture Exchange (the ‘TSXV‘), it has entered into an agreement with a private arm’s length British Columbia company under which it has agreed to sell all of the issued and outstanding Class ‘A’ shares and Class ‘B’ common shares in the capital (collectively the ‘Apolo Shares‘) of Minera Apolo, S.A. de C.V. (‘Apolo‘), which owns all the issued and outstanding shares of Minera Catanava, S.A. de C.V. (‘MC‘). Apolo and MC collectively hold a 100% interest in the Pinos gold/silver project (‘Pinos‘) located in Zacatecas State, the second largest mining state in Mexico. Pinos comprises 30 contiguous mining concessions over 3,816 hectares. The sale of Apolo is an Arm’s Length Transaction and there are no finder’s fees payable.

Ralph Shearing, Chief Executive Officer, commented: ‘Having received an unsolicited bid for Pinos, management determined that it would be the best use of the Company’s resources to dispose of the Pinos asset based on the Company’s recent acquisition of the San Francisco gold mine, which is a much larger and more advanced project than Pinos. The Company’s focus will be the continued development and optimization of our flagship Cerro Prieto heap-leach gold mine and advancing towards a re-start of gold production at the San Francisco gold mine (see news release dated December 24, 2025). Both assets are located within 44km in a straight line from each other in the state of Sonora, Mexico. The San Francisco gold mine represents a unique opportunity to consolidate a highly prospective gold district.’ Mr. Shearing further stated: ‘At this stage of our Company’s development, with Pinos being a non-core asset, management and the board of directors has elected to monetize Pinos with an attractive, high cash purchase offer, deploying the sale proceeds towards Cerro Prieto optimization and re-starting gold production at San Francisco.

Under the terms of the Share Purchase Agreement, Goldgroup has agreed to sell all the Apolo Shares to a private arm’s length British Columbia company (the ‘Purchaser‘) in consideration of the payment to Goldgroup of US$5,000,000 in stages, with US$2,450,000 deposit payable on signing which will be refunded if the transaction does not close by February 16, 2026, US$550,000 to be paid on closing and US$2,000,000 to be secured by a Promissory Note and paid on or before the date that is six (6) months from the Closing Date. Further, the Purchaser has agreed to assume any and all liabilities of Goldgroup associated with Apolo, MC and the Pinos project, including the assumption of US$400,000 remaining payable on the original purchase agreement in addition to debt in the amount of US$1,500,000 payable to the previous owners of Apolo that will be triggered by the sale of Apolo. Goldgroup, the Purchaser and the previous owners of Apolo have also agreed to enter an Assumption and Acknowledgement Agreement under which the previous owners acknowledge and agree that they will have no further recourse against Goldgroup for any liabilities related to Apolo, MC and the Pinos project, all of which have been assumed by the Purchaser.

Cautionary Statement
The closing of the sale of Apolo is subject to the approval of the TSX Venture Exchange.

Clarification regarding Investor Relations Agreement
At the request of the TSXV, Goldgroup wishes to clarify its news release of October 13, 2025, regarding the retention of Machai Capital Inc. to provide digital marketing services on behalf of the Company. Goldgroup advises that it paid Machai Capital Inc. $200,000 as an upfront fee. Further Goldgroup advises that neither Machai Capital Inc. nor its principal Suneal Sandhu owned any securities of Goldgroup as at October 13, 2025.

About Goldgroup
Goldgroup is a Canadian-based mining Company with two high-growth gold assets in Mexico. In addition to the San Francisco gold mine, the Company has a 100% interest in the producing Cerro Prieto heap-leach gold mine located in the State of Sonora. An optimization and exploration program is underway at Cerro Prieto to significantly increase existing production and resources. The acquisition of Molimentales del Noroeste, S.A. de C.V. (‘Molimentales‘), the owner of the San Francisco gold mine is subject to final approval from the TSXV.

Goldgroup is led by a team of highly successful and seasoned individuals with extensive expertise in mine development, corporate finance, and exploration in Mexico.

For further information on Goldgroup, please visit www.goldgroupmining.com

On behalf of the Board of Directors

‘Ralph Shearing’
Ralph Shearing, CEO

For more information:
+1 (604) 306-6867
410 – 1111 Melville St.
Vancouver, BC, V6E 3V6
www.goldgroupmining.com
ir@goldgroupmining.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

CAUTIONARY NOTES REGARDING FORWARD-LOOKING INFORMATION
Certain information contained in this news release, including any information relating to future financial or operating performance, may be considered ‘forward-looking information’ (within the meaning of applicable Canadian securities law) and ‘forward-looking statements’ (within the meaning of the United States Private Securities Litigation Reform Act of 1995). These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Actual results could differ materially from the conclusions, forecasts and projections contained in such forward-looking information.

These forward-looking statements reflect Goldgroup’s current internal projections, expectations or beliefs and are based on information currently available to Goldgroup. In some cases forward-looking information can be identified by terminology such as ‘may’, ‘will’, ‘should’, ‘expect’, ‘intend’, ‘plan’, ‘anticipate’, ‘believe’, ‘estimate’, ‘projects’, ‘potential’, ‘scheduled’, ‘forecast’, ‘budget’ or the negative of those terms or other comparable terminology. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Forward-looking information is subject to a variety of known and unknown risks, uncertainties and other factors that could cause actual events or results to materially differ from those reflected in the forward-looking information, and are developed based on assumptions about such risks, uncertainties and other factors including, without limitation: receipt of all required TSXV, regulatory and other interested party approvals in connection with the Concurso Mercantilprocess; uncertainties related to actual capital costs operating costs and expenditures; production schedules and economic returns from Goldgroup’s projects; timing to integrate acquisitions (San Francisco Mine) and timing to complete additional exploration and technical reports; uncertainties associated with development activities; uncertainties inherent in the estimation of mineral resources and precious metal recoveries; uncertainties related to current global economic conditions; fluctuations in precious and base metal prices; uncertainties related to the availability of future financing; potential difficulties with joint venture partners; risks that Goldgroup’s title to its property could be challenged; political and country risk; risks associated with Goldgroup being subject to government regulation; risks associated with surface rights; environmental risks; Goldgroup’s need to attract and retain qualified personnel; risks associated with potential conflicts of interest; Goldgroup’s lack of experience in overseeing the construction of a mining project; risks related to the integration of businesses and assets acquired by Goldgroup; uncertainties related to the competitiveness of the mining industry; risk associated with theft; risk of water shortages and risks associated with competition for water; uninsured risks and inadequate insurance coverage; risks associated with potential legal proceedings; risks associated with community relations; outside contractor risks; risks related to archaeological sites; foreign currency risks; risks associated with security and human rights; and risks related to the need for reclamation activities on Goldgroup’s properties, as well as the risk factors disclosed in Goldgroup’s MD&A. Any and all of the forward-looking information contained in this news release is qualified by these cautionary statements.

Although Goldgroup believes that the forward-looking information contained in this news release is based on reasonable assumptions, readers cannot be assured that actual results will be consistent with such statements. Accordingly, readers are cautioned against placing undue reliance on forward-looking information. Goldgroup expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise, except as may be required by, and in accordance with, applicable securities laws.

SOURCE: Goldgroup Mining, Inc.

View the original press release on ACCESS Newswire

News Provided by ACCESS Newswire via QuoteMedia

This post appeared first on investingnews.com

Rio Silver Inc. (‘Rio Silver’ or the ‘Company’) is pleased to announce that it has settled an aggregate of $293,250 of indebtedness (the ‘Debts’) through (1) the issuance of an aggregate of 1,396,428 common shares of the Company at a deemed issuance price of $0.21 per share, of which 976,190 shares were issued to non-arm’s length creditors; and (2) the issuance of an aggregate of 420,238 common share purchase warrants entitling the holders to purchase an aggregate of 420,238 common shares of the Company at a price of $0.28 per share until December 31, 2028, none of which share purchase warrants were issued to non-arm’s length creditors. All common shares and share purchase warrants issued to settle the Debts will be subject to a hold period expiring May 1, 2026. Completion of the securities for debt transaction will allow the Company to improve its current working capital deficiency position.

About Rio Silver Inc.

Rio Silver Inc. (TSX-V: RYO | OTC: RYOOF) is a Canadian resource company advancing high-grade, silver-dominant assets in Peru, the world’s second-largest silver producer. The Company is focused on near-term development opportunities within proven mineral belts and is supported by a seasoned technical and operational team with deep experience in Peruvian geology, underground mining, and district-scale exploration. With a clear development strategy, and a growing portfolio of highly prospective silver assets, Rio Silver is establishing the foundation to become one of Peru’s next emerging silver producers. Learn more at www.riosilverinc.com.

ON BEHALF OF THE BOARD OF DIRECTORS OF Rio Silver INC.

Chris Verrico
President, Chief Executive Officer and a Director

To learn more or engage directly with the Company, please contact:

Christopher Verrico, President and CEO
Tel: (604) 762-4448
Email: chris.verrico@riosilverinc.com
Website: www.riosilverinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Information: This news release includes forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements.

News Provided by GlobeNewswire via QuoteMedia

This post appeared first on investingnews.com

Sankamap Metals Inc. (CSE: SCU) (‘Sankamap’ or the ‘Company’) the Company and its auditor continue to work diligently toward the completion and filing of the Company’s annual audited financial statements and management’s discussion and analysis for the fiscal year ended June 30, 2025 (the ‘Required Filings’). The Company has applied to the Alberta Securities Commission for an extension of the Management Cease Trade Order (‘MCTO’), however, there can be no assurance that a further extension will be granted. The additional delay in completing the Required Filings is primarily due to the auditor awaiting the receipt of certain required information from government authorities in Solomon Islands, as well as timing constraints associated with the holiday period. The Company estimates that approximately 90% of the audit work has been completed.

The Required Filings were due to be filed by October 28, 2025. In connection with the anticipated delays in making the Required Filings, the Company made an application for a Management Cease Trade Order (‘MCTO‘) under National Policy 12-203 Management Cease Trade Orders (‘NP 12-203‘) to the Alberta Securities Commission, as principal regulator for the Company, and the MCTO was issued on October 29, 2025. The MCTO restricts all trading by the Company’s CEO and CFO in securities of the Company, whether direct or indirect. The MCTO does not affect the ability of persons who are not directors, officers or insiders of the Company to trade their securities. The MCTO will remain in effect until the Required Filings are filed or until it is revoked or varied.

The Company expects to proceed with the filing of its interim first-quarter financial statements shortly after the Required Filings have been completed and submitted.

The Company confirms that it intends to satisfy the provisions of the alternative information guidelines described in NP 12-203 by issuing bi-weekly default status reports in the form of a news release until it meets the Required Filings requirement. The Company has not taken any steps towards any insolvency proceeding and the Company has no material information relating to its affairs that has not been generally disclosed.

For further information with respect to the MCTO, please refer to the Company’s news releases dated October 21, 2025, November 4, 2025, November 18, 2025, December 3, 2025 and December 17, 2025, available for viewing on the Company’s SEDAR+ profile at www.sedarplus.ca.

About Sankamap Metals Inc.

Sankamap Metals Inc. (CSE: SCU) is a Canadian mineral exploration company dedicated to the discovery and development of high-grade copper and gold deposits through its flagship Oceania Project, located in the South Pacific. The Company’s fully permitted assets are strategically positioned in the Solomon Islands, along a prolific geological trend that hosts major copper-gold deposits; including Newcrest’s Lihir Mine, with a resource of 71.9 million ounces of gold¹ (310 Mt containing 23 Moz Au at 2.3 g/t P+P, 520 Mt containing 39 Moz Au at 2.3 g/t indicated, 81 Mt containing 5 Moz Au at 1.9 g/t measured, 61 Mt containing 4.9 Moz Au at 2.3 g/t Inferred).

Exploration is actively advancing at both the Kuma and Fauro properties, part of Sankamap’s Oceania Project in the Solomon Islands. Historical work has already highlighted the mineral potential of both sites, which lie along a highly prospective copper and gold-bearing trend, suggesting the possibility of further, yet-to-be-discovered deposits.

At Kuma, the property is believed to host an underexplored and largely untested porphyry copper-gold (Cu-Au) system. Historical rock chip sampling has returned consistently elevated gold values above 0.5 g/t Au, including a standout sample assaying 11.7% Cu and 13.5 g/t Au2; underscoring the area’s significant potential.

At Fauro, particularly at the Meriguna Target, historical trenching has returned highly encouraging results, including 8.0 meters at 27.95 g/t Au and 14.0 meters at 8.94 g/t Au3. Complementing these results are exceptional grab sample assays, including historical values of up to 173 g/t Au3, along with recent sampling by Sankamap at the Kiovakase Target, which returned numerous high-grade copper values, reaching up to 4.09% Cu. In addition, limited historical shallow drilling intersected 35.0 meters at 2.08 g/t Au3, further underscoring the property’s strong mineral potential and the merit for continued exploration. With a commitment to systematic exploration and a team of experienced professionals, Sankamap aims to unlock the untapped potential of underexplored regions and create substantial value for its shareholders. For more information, please refer to SEDAR+ (www.sedarplus.ca), under Sankamap’s profile.

1.Newcrest Technical Report, 2020 (Lihir: 310 Mt containing 23 Moz Au at 2.3 g/t P+P, 520 Mt containing 39 Moz Au at 2.3 g/t indicated, 81 Mt containing 5 Moz Au at 1.9 g/t measured, 61 Mt containing 4.9 Moz Au at 2.3 g/t Inferred)

2. Historical grab, soil and BLEG samples from SolGold Kuma Review June 2015, and SolGold plc Annual Report 2013/2012

3. September 2010-June 2012 press releases from Solomon Gold Ltd. and SolGold Fauro Island Summary Technical Info 2012

QP Disclosure

The technical content for the Oceania Project in this news release has been reviewed and approved by John Florek, M.Sc., P.Geol., a Qualified Person in accordance with CIM guidelines. Mr. John Florek is in good standing with the Professional Geoscientists of Ontario (Member ID:1228) and a director and officer of the Company.

ON BEHALF OF THE BOARD OF DIRECTORS

s/ ‘John Florek’
John Florek, M.Sc., P.Geol
Chief Executive Officer
Sankamap Metals Inc.

Contact:
John Florek, CEO
T: (807) 228-3531
E: johnf@sankamap.com

The Canadian Securities Exchange has not approved nor disapproved this press release.

Forward-Looking Statements

Certain statements made and information contained herein may constitute ‘forward-looking information’ and ‘forward-looking statements’ within the meaning of applicable Canadian and United States securities legislation. These statements and information are based on facts currently available to Sankamap and there is no assurance that the actual results will meet management’s expectations. Forward-looking statements and information may be identified by such terms as ‘anticipates,’ ‘believes,’ ‘targets,’ ‘estimates,’ ‘plans,’ ‘expects,’ ‘may,’ ‘will,’ ‘could’ or ‘would.’

This press release contains forward-looking statements, including, but not limited to, statements regarding management’s expectations about obtaining the MCTO and completing the Required Filings within the anticipated timeline. Forward-looking statements are subject to various risks, uncertainties, and other factors that could cause actual results or events to differ materially from those expressed or implied by such statements. Sankamap does not undertake any obligation to update forward-looking statements or information, except as required by applicable securities laws. For more information on the Company, investors should review the Company’s continuous disclosure filings that are available at www.sedarplus.ca.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/279270

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to breakthrough innovations and increased deals involving NASDAQ biotech stocks.

After dropping to a low of 3,637.05 in October 2023, the index climbed to a nearly three year peak of 4,954.813 on September 19, 2024. While the index pulled back to 4,530.69 in August 2025, it staged a robust recovery in the second half of the year, closing at 5,766.59 on December 29, 2025, a gain of approximately 34 percent for the year.

The top NASDAQ biotech stocks have seen sizeable share price increases over the past year. For those interested in investing in biotech companies, the best-performing small-cap biotech stocks are outlined below.

Data was gathered on December 29, 2025, using TradingView’s stock screener. Small-cap biotech stocks with market caps between US$50 million and US$500 million at that time were considered for this list.

1. SELLAS Life Sciences Group (NASDAQ:SLS)

Year-to-date gain: 210.19 percent
Market cap: US$477.18 million
Share price: US$3.35

SELLAS Life Sciences Group is a late-stage biopharmaceutical company focused on novel cancer immunotherapies. The company’s approach involves ‘teaching’ the immune system to recognize and kill cancer cells by targeting specific proteins that are overexpressed in tumors.

Its flagship asset is galinpepimut-S (GPS), a vaccine-like immunotherapy for patients with acute myeloid leukemia (AML) who are in remission but at high risk of relapse. Its secondary asset, SLS009, is a highly selective CDK9 inhibitor currently showing promise in Phase 2 trials for various blood cancers.

The company’s stock price surged on December 29 after SELLAS shared an update on the Phase 3 REGAL trial evaluating GPS as a maintenance therapy in patients with AML. The trial is designed as a blind survival study, with the end point triggered on the 80th patient death.

In the update, the company reported that 72 deaths had occurred as of December 26. Because it is taking longer than expected for the trial to complete, which was previously anticipated to happen before the end of 2025, investors are speculating that the patients in the trial are living significantly longer than the historical average.

2. IO Biotech (NASDAQ:IOBT)

Year-to-date gain: 129.47 percent
Market cap: US$144.28 million
Share price: US$2.16

IO Biotech is developing immune-modulating therapeutic cancer vaccines based on its T-win technology platform, designed to activate T cells to target both tumor cells and the immune-suppressive cells.

The clinical-stage biopharmaceutical company’s lead cancer vaccine candidate is IO102-IO103, which has the brand name Cylembio. IO102-IO103 has breakthrough therapy designation from the US Food and Drug Administration (FDA) when used in combination with Merck’s (NYSE:MRK) anti-PD-1 therapy Keytruda for the treatment of advanced melanoma based on positive Phase 1/2 first line metastatic melanoma data.

The candidate reached a major milestone in August 2025 with the readout of its pivotal Phase 3 trial of IO102-IO103 with Keytruda for treating advanced melanoma. While the vaccine combined with Keytruda showed a significant survival benefit — reaching 19.4 months of progression-free survival compared to 11 months for Keytruda alone — it narrowly missed the strict statistical significance threshold.

Following a December meeting with the FDA to discuss a path forward for Cylembio, IO Biotech ended the year focused on a new registrational trial to address the Phase 3 miss and securing further funding to extend its operations into 2026.

Throughout 2025, the company continued to expand its pipeline. In November, it presented new pre-clinical data for IO112 targeting arginase 1 and for IO170 targeting transforming growth factor.

3. Tiziana Life Sciences (NASDAQ:TLSA)

Year-to-date gain: 124.64 percent
Market cap: US$184.22 million
Share price: US$1.55

Tiziana Life Sciences is a clinical-stage biopharma which is developing therapies for autoimmune and inflammatory diseases, degenerative diseases and cancer-related to the liver. Its pipeline of candidates is built on its patented drug delivery technology that provides a possible alternative to intravenous delivery.

Tiziana’s lead candidate is intranasal foralumab, a fully human anti-CD3 monoclonal antibody, which it is currently studying for treatment of a range of conditions.

In March, the company filed an investigational new drug application with the FDA for a Phase 2 clinical trial in amyotrophic lateral sclerosis (ALS), which is supported by the ALS Association. The Phase 2 trial is slated to begin in January 2026. Tiziana also began dosing patients in a Phase 2a trial for multiple system atrophy in August.

In April, John Hopkins University and the University of Massachusetts commenced dosing of the biotech company’s intranasal foralumab in Phase 2 trials for patients with non-active secondary progressive multiple sclerosis (MS). On May 7, the company shared positive results from the use of its lead candidate in improving the quality of life for patients with that form of MS.

Tiziana is also studying the use of intranasal foralumab for treating moderate Alzheimer’s disease. On May 9, it announced that PET scans of a patient with moderate Alzheimer’s showed a significant reduction in microglia activation associated with neuroinflammation after three months of treatment.

On July 21, the company announced an ‘unexpected discovery’ following immunologic analysis of the patient with Alzheimer’s disease: ‘The analysis revealed an increase in phagocytosis markers in classical monocytes, suggesting that nasal foralumab may enhance their ability to clear amyloid plaques. This unexpected effect may open new avenues for treating Alzheimer’s Disease by targeting both inflammation and amyloid accumulation.’

The company dosed the first patient in its randomized Phase 2 Alzheimer’s trial in December.

To end the year, Tiazana submitted a comprehensive safety report to the FDA documenting over 37 patient-years of treatment with no serious drug-related adverse events across its studies.

4. Spero Therapeutics (NASDAQ:SPRO)

Year-to-date gain: 119.05 percent
Market cap: US$129.58 million
Share price: US$2.30

Spero Therapeutics is developing novel treatments for rare diseases and multi-drug resistant bacterial infections with high unmet need.

The company’s lead drug candidate is tebipenem pivoxil hydrobromide (HBr), a late-stage development asset developed in collaboration with pharma giant GSK (NYSE:GSK). GSK has an exclusive license agreement to commercialize the drug candidate in most markets.

Tebipenem HBr is an oral carbapenem developed to treat complicated urinary tract infections (cUTIs), including pyelonephritis. The FDA granted tebipenem HBr qualified infectious disease product and fast-track designations.

Spero’s stock surged 245 percent on May 28 to reach US$2.35 after the company reported that its Phase 3 trial evaluating tebipenem HBr for treating cUTIs met its primary endpoint and stopped early for efficacy.

On December 19, GSK officially filed the new drug application resubmission to the FDA for tebipenem HBr for treating cUTIs supported by the Phase 3 results. This filing triggered a US$25 million milestone payment to Spero that is expected in Q1 2026.

5. OKYO Pharma (NASDAQ:OKYO)

Year-to-date gain: 60.50 percent
Market cap: US$74.85 million
Share price: US$1.91

OKYO Pharma is a clinical-stage biopharma company developing therapies for the treatment of neuropathic corneal pain and dry eye disease. Its lead candidate is urcosimod, a non-steroidal anti-inflammatory and non-opioid analgesic.

OKYO is currently evaluating urcosimod for the treatment of neuropathic corneal pain. The treatment received fast track designation from the FDA in May after the company ended its Phase 2 clinical trial early to analyze data.

On July 17, the company posted strong top-line data from the Phase 2 trial and stated it is planning a meeting with the FDA to discuss next steps for its lead drug candidate. The following day, OKYO received US$1.9 million in non-dilutive funding to support its clinical development of urcosimod.

In September, OKYO announced a 120 patient, multi-center multiple ascending dose clinical trial designed to identify the optimal dose for Phase 3 registration.

A scientific breakthrough followed on December 11, when new imaging data revealed that urcosimod may actually help restore corneal nerve structure, showing median increases in nerve fiber count and length, while those in the placebo group saw median decreases for both.

Securities Disclosure: I, Meagan Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

LONDON, UNITED KINGDOM / ACCESS Newswire / December 30, 2025 / Empire Metals Limited (AIM:EEE)(OTCQX:EPMLF), the AIM-quoted and OTCQX-traded exploration and development company, is pleased to announce that it has entered into a conditional sale and purchase agreement for its 75% interest in the Eclipse Mining Lease (‘Eclipse ML’ or the ‘Project’), a non-core gold asset located near Kalgoorlie, Western Australia.

The agreement includes a three-month exclusivity and due diligence period, during which the proposed purchaser will complete technical and commercial due diligence on the Project.

Highlights

  • Conditional sale of Empire’s 75% interest in the Eclipse ML, a non-core gold asset

  • Purchaser is a reputable Western Australian mining services company operating in the Kalgoorlie region

  • Total consideration of A$750,000 cash for Empire’s interest, subject to successful completion of due diligence

  • Transaction supports Empire’s strategy to focus capital and resources on the Pitfield Titanium Project

Shaun Bunn, Managing Director, said: ‘This conditional sale represents a further step in our strategy to streamline the portfolio and focus management attention and capital on advancing the Pitfield Project. Eclipse is a non-core asset for Empire, and this transaction provides an opportunity to unlock value while reducing ongoing holding and resourcing costs. We look forward to progressing the due diligence phase with the purchaser.’

The Eclipse ML Project

The Eclipse ML is a small granted mining lease located near Kalgoorlie, Western Australia, which has historically been subject to gold exploration. As part of its broader portfolio rationalization strategy, Empire has been actively reviewing options to reduce exposure to non-core assets and is pleased to have entered into an exclusivity arrangement with the purchaser in respect of its interest in the Project.

Sale Terms

Key terms of the conditional sale agreement include:

  • The sale relates to Empire’s 75% interest in mining lease M27/153 (Eclipse ML)

  • The agreement includes a three-month exclusivity and due diligence period

  • During the exclusivity period, the purchaser may conduct a small RC drilling programme as part of its due diligence

  • Total consideration of A$750,000 for Empire’s 75% interest, comprising:

    • A$50,000 non-refundable cash deposit, payable within five days of execution of the agreement; and

    • A$700,000 cash payable on completion, following successful due diligence

Next Steps

The anticipated next steps are as follows:

  • The due diligence period last three months, to be conducted by the Purchaser.

  • A Program of Works has been submitted to the Department of Mines, Petroleum and Exploration (DMPE) to support a small drill campaign, to be funded by the Purchaser

  • Subject to a successful due diligence period, settlement is expected to occur in early April.

  • Empire continues to review options for other non-core assets, consistent with its strategy to accelerate development activities at the Pitfield Project.

**ENDS**

For further information please visit www.empiremetals.co.uk or contact:

Empire Metals Ltd
Shaun Bunn / Greg Kuenzel / Arabella Burwell

Tel: 020 4583 1440

S. P. Angel Corporate Finance LLP (Nomad & Joint Broker)
Ewan Leggat / Adam Cowl

Tel: 020 3470 0470

Canaccord Genuity Limited (Joint Broker)
James Asensio / Christian Calabrese / Charlie Hammond

Tel: 020 7523 8000

Shard Capital Partners LLP (Joint Broker)
Damon Heath

Tel: 020 7186 9950

Tavistock (Financial PR)
Emily Moss / Josephine Clerkin

empiremetals@tavistock.co.uk
Tel: 020 7920 3150

About Empire Metals Limited

Empire Metals Ltd (AIM:EEE)(OTCQX:EPMLF) is an exploration and resource development company focused on the commercialization of the Pitfield Titanium Project, located in Western Australia. The titanium discovery at Pitfield is of unprecedented scale and hosts one of the largest and highest-grade titanium resources reported globally, with a Mineral Resource Estimate (MRE) totalling 2.2 billion tonnes grading 5.1% TiO₂ for 113 million tonnes of contained TiO₂.

Titanium mineralisation at Pitfield occurs from surface and displays exceptional grade continuity along strike and down dip. The MRE extends across just 20% of the known mineralised footprint, providing substantial potential for further resource expansion.

Conventional processing has already produced a high-purity product grading 99.25% TiO₂, suitable for titanium sponge metal or pigment feedstock. With excellent logistics and established infrastructure, Pitfield is strategically positioned to supply the growing global demand for titanium and other critical minerals.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Empire Metals Limited

View the original press release on ACCESS Newswire

News Provided by ACCESS Newswire via QuoteMedia

This post appeared first on investingnews.com

Silver’s 2025 breakout marked one of the metal’s most decisive shifts in more than a decade.

As the price pushed through longstanding resistance, investors, miners and policymakers reassessed its role in global markets, allowing silver to reassert itself as not only an industrial metal, but also a staple financial asset.

Looking back at silver’s record-breaking year, these are our most popular news stories of 2025.

1. Retail Investors Look to Trigger Silver Squeeze 2.0

Publish date: March 31, 2025

Silver received mainstream attention in March, with renewed calls for what supporters dubbed “Silver Squeeze 2.0,” reviving a theme that first gained prominence during the meme stock era of 2021.

Online chatter intensified ahead of March 31, with advocates urging coordinated purchases of physical silver to challenge what they saw as entrenched institutional control over the metal’s pricing.

Efforts traced back to a March 22 post on X by user @TheSqueakyMouse, which gained broader attention after being amplified by sector analyst Jesse Colombo. Colombo, who posts under the handle @TheBubbleBubble, has argued that the silver price is artificially suppressed by large financial institutions:

“Bullion banks like JPMorgan Chase (NYSE:JPM) and UBS Group (NYSE:UBS) suppress silver prices through aggressive naked shorting—but a coordinated surge of physical buying could catch them off guard and break their hold on the market.’

Colombo pointed to data showing that major banks hold net short positions equivalent to roughly 223 million ounces of silver, meaning a US$1 price increase could theoretically translate into US$223 million in losses for those positions.

2. Missouri Set to Recognize Gold and Silver as Legal Tender, Critics Raise Implementation Concerns

Publish date: May 12, 2025

Attention on precious metals took a more concrete form in Missouri. In May, the state’s General Assembly passed a Republican-backed amendment to a broader finance bill that recognizes gold and silver as legal tender.

The measure would require state entities to accept electronic forms of gold and silver for public debts, including taxes. Private businesses would not be required to accept precious metals, but could do so voluntarily.

Supporters argued that recognizing gold and silver offers a hedge against inflation and what they view as irresponsible federal monetary policy. Critics, however, questioned how the system would work in practice.

3. Silver Miners Deliver Record Q2 Earnings as Price Breaks Out

Publish date: August 19, 2025

Silver’s mid-year rally above US$35 per ounce translated into record or near-record earnings for many miners in Q2.

Pan American Silver (TSX:PAAS) reported record net earnings of US$189.6 million in the period, while First Majestic Silver (TSX:AG,NYSE:AG) posted its strongest quarter to date, nearly doubling revenue year-on-year.

Even mining companies facing production challenges, such as Fresnillo (LSE:FRES,OTC Pink:FNLPF), saw revenue growth driven by gold output and pricing strength.

4. Missing Silver Bars Bring Mining Community Together

Publish date: March 7, 2025

Amid those financial milestones, the mining community was united in March by a widely shared incident.

Following the Prospectors & Developers Association of Canada convention, two 10 ounce silver bars purchased by Kin Communications founder Arlen Hansen went missing after being checked in his luggage on an Air Canada flight.

The bars, worth about US$647, were intended for a silent auction benefiting Canadian children living with diabetes.

“I don’t need a refund, a free upgrade, or more points, this was stolen from the children who need it, not me,” Hansen wrote on X. The response from the mining community was swift. First Majestic Silver and its mint division volunteered to replace the lost silver, while others donated to Diabetes Canada and expressed support.

The incident also revived scrutiny of airline cargo security, particularly given Air Canada’s association with earlier high-profile precious metals thefts, including the 2023 gold heist at Toronto Pearson International Airport.

5. Pan American Silver Gets Green Light for US$2.1 Billion MAG Silver Deal

Publish date: August 25, 2025

One of this year’s most consequential silver M&A developments came when Pan American received final clearance from Mexico’s Federal Economic Competition Commission for its US$2.1 billion acquisition of MAG Silver.

The approval paved the way for the deal to close in early September, combining Pan American with one of the world’s highest-grade primary silver assets, Juanicipio.

Under the terms, MAG shareholders were to receive either cash or Pan American shares, leaving them with about 14 percent of the combined company on a fully diluted basis.

“This strategic acquisition further solidifies Pan American as a leading Americas-focused silver producer,” Pan American CEO Michael Steinmann said when the deal was announced.

He added that Juanicipio “will meaningfully increase Pan American’s exposure to high margin silver ounces,” while also providing longer-term growth through MAG’s exploration properties in Utah and Ontario.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com